A General Electric Healthcare [Physician] Investor Update

Enabling precision health PODCAST

Hi David, and all ME-P Readers and Subscribers

We’re proud to be a part of improving patient lives globally with precision health – personalizing diagnoses and treatments in a smarter and more efficient way.

In case you missed it, last week GE Healthcare’s Pharmaceutical Diagnostics business (PDx) announced the acquisition of Zionexa, a leading innovator of in-vivo oncology and neurology biomarkers that help enable more personalized healthcare.

Healthcare will scale Zionexa’s FDA-approved PET imaging agent Cerianna, which is used as an adjunct to biopsy for the detection of estrogen receptor (ER) positive lesions to help inform treatment selection for patients with recurrent or metastatic breast cancer.

This is the essence of precision health, and our continued commitment to innovation. Read more about Zionexa here.

And, as a reminder, Carolina will be participating in a fireside chat on May 12 at 12:10pm EDT during the Goldman Sachs Industrials & Materials Conference. We hope you and all interested ME-P readers and subscribers will tune in.

GE Healthcare logo

Best,
Steve Winoker

[GE Corporate]

Boston, MA

2 Responses

  1. Hi David,

    In the spirit of continuous improvement and creating a newsletter that best serves you, we would appreciate your time to provide feedback on our GE Investor Updates and the company.

    Please use the link below to share your opinion with us – it just takes a moment.
    https://www.surveymonkey.com/r/6XR8Y9N

    Thanks for your feedback and continued interest in GE,

    Steve

    Like

  2. Hi David,

    I hope this e-mail finds you and your family well.

    Over the past two weeks, we’ve been busy here at GE. Our senior leadership team has been “on the road” participating in virtual investor conferences and meetings. In case you missed it, Larry presented in a fireside chat at Bernstein’s 37th Annual Strategic Decisions Conference. He provided perspective on how GE’s transformation to a more focused, simpler and stronger high-tech industrial company is accelerating, offering insight from our quarterly operating reviews within each business. We also shared that the U.S. Department of Justice concluded its review of the GECAS and AerCap combination. Additionally, Carolina attended the UBS Global Industrials & Transportation Conference and the Wolfe Global Transportation & Industrials Conference, and GE Healthcare CEO Kieran Murphy participated in the Goldman Sachs Healthcare Conference.

    As we continue to strengthen GE for the future, we’ve acted opportunistically to advance our deleveraging plan. On June 8, we announced the results of our most recent debt tender, using cash on hand to repurchase $7 billion of debt, an upsize from our original expectations. Since the end of 2018, we’ve reduced gross debt by approximately $50 billion as part of our effort towards achieving our leverage target of less than 2.5x net debt to EBITDA.

    At the same time, we’re shifting more towards offense. We’re focused on organic growth first, complemented by inorganic investments to support our businesses. On June 9, we announced that Prolec GE, a 50/50 joint venture between GE and Xignux, plans to acquire SPX’s Transformer Solutions business for $645 million. The acquisition will enhance Prolec GE’s position as a key power and distribution transformers player providing customers with a wider choice of products and an enhanced next-generation portfolio in the Americas. We expect the transaction to close by the end of 2021.

    Finally, I’ll leave you with some words from Larry at the Bernstein conference last week… “I can be excited about the momentum I saw across the businesses here over the last five weeks, but we know there’s a lot more to do… Over time, I think we are going to create a lot of value, and have that resonate both with customers and with investors.”

    Thank you for your continued interest in GE,

    Steve

    Like

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: